Related Experiment Video
Updated: Aug 8, 2026

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
Published on: June 28, 2019
[Antiapoptotic oncogene bcl-2 induces a program of senescence in E1A + c-Ha-ras-transformants treated with
Abstract:
Introduction of bcl-2 gene in EIA + c-Ha-ras-transformed rat embryo fibroblasts, which are unable to be arrested after damaging influences and possess high proapoptotic sensitivity, results not only in suppression of cell death but also in re-establishment of cell cycle block following DNA damage and serum starvation. Flow cytometry showed that E1A + c-Ha-ras + bcl-2-transformants treated with DNA-intercalator adriamycin are capable of being arrested at G1/S boundary for a long time (for less than 5 days). According to the growth curve data, the number of Bcl-2-overexpressing cells remanins constant for a week of cultivation with adriamycin. Clonogenic efficacy of E1A + c-Ha-ras + bcl-2-cells is brought to no already in 16 h after adriamycin addition. Apoptotic death, revealed by oligonucleosomic fragmentation of DNA, as well as cell death, occurring due to mitotic catastrophe, after adriamycin treatment are almost absent in Bcl-2-overexpressing transformants, as compared with parental E1A + c-Ha-ras-transformants. Bcl-2 introduction in E1A + c-Ha-ras-transformants is accompanied by a rise of SA beta-Gal (Senescence Associated beta-Galactosidase) activity, which is commonly considered to be a marker of cell senescence. Adriamycin treatment of E1A + c-Ha-ras + bcl-2-transformants results in a much higher rise in SA beta-Gal activity, as compared with untreated cells. Co-immunoprecipitation experiments demonstrated the introduction of Bcl-2 to result in formation of Bcl-2 complexes with early region E1A oncoproducts, which are thought to be responsible for proapoptotic susceptibility of E1A-expressing transformants. The data obtained lead to suggestion that bcl-2 transfer to E1A + c-Ha-ras-transformants may induce a switch from the cell death program on the program of senescence after DNA damage, due, presumably, to Bcl-2 interaction with the apoptosis activator the viral oncoprotein E1A.
Insights
Introducing the bcl-2 gene into cancer cells suppresses cell death and restores cell cycle arrest after DNA damage. This suggests bcl-2 may switch cells from death to senescence pathways.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- E1A + c-Ha-ras-transformed rat embryo fibroblasts exhibit high apoptosis sensitivity and lack cell cycle arrest after DNA damage.
- The bcl-2 gene is a key regulator of apoptosis.
Purpose of the Study:
- To investigate the effect of bcl-2 gene introduction on cell death and cell cycle regulation in E1A + c-Ha-ras-transformed fibroblasts.
- To explore the potential switch from apoptosis to senescence pathways induced by bcl-2.
Main Methods:
- Introduction of the bcl-2 gene into transformed fibroblasts.
- Treatment with the DNA-intercalator adriamycin.
- Flow cytometry for cell cycle analysis.
- Growth curve analysis.
- Clonogenic assays.
- Measurement of Senescence-Associated beta-Galactosidase (SA β-Gal) activity.
- Co-immunoprecipitation to study protein interactions.
Main Results:
- Bcl-2 introduction suppressed adriamycin-induced apoptosis and mitotic catastrophe.
- Cells expressing bcl-2 were arrested at the G1/S boundary and maintained viability during adriamycin treatment.
- Bcl-2 overexpression led to increased SA β-Gal activity, a marker of senescence.
- Co-immunoprecipitation revealed Bcl-2 complex formation with the viral oncoprotein E1A.
Conclusions:
- Bcl-2 gene transfer can prevent apoptosis and restore cell cycle arrest in E1A + c-Ha-ras-transformed cells.
- Bcl-2 may induce a switch from cell death to senescence following DNA damage, potentially through interaction with E1A.
More Related Videos
10:08Senescence Detection Using Reflected Light in Adipose Stromal Vascular Fraction
Published on: June 5, 2026
13:59A Quantitative Measurement of Reactive Oxygen Species and Senescence-associated Secretory Phenotype in Normal Human Fibroblasts During Oncogene-induced Senescence
Published on: August 12, 2018
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Ras Gene
Ras is a superfamily...
Abnormal Proliferation
Cellular Injury V: Apoptosis and Autophagy
Replicative Cell Senescence